Ronit Simantov - 12 Jul 2021 Form 4 Insider Report for Clovis Oncology, Inc.

Role
Director
Signature
/s/ Ronit Simantov
Issuer symbol
N/A
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
13 Jul 2021, 16:25:24 UTC
Next filing
10 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLVS Stock Option (right to buy) Award $0 +83,212 $0.000000 83,212 12 Jul 2021 Common Stock 83,212 $5.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the shares subject to the option shall vest on each of the first three (3) annual anniversaries of the date of grant.